Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Case Report

Clivus and Dural Involvement in a Case of Multiple Myeloma: A Rare Complication of Multiple Myeloma

Authors: Manish Bhartiya, Aditya Pachisia, Rajan Kapoor, Vasu Vardhan

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Excerpt

Multiple myeloma (MM) represents a malignant proliferation of plasma cells derived from a single clone. The tumor, its products, and the host response to it result in a number of organ dysfunctions and symptoms, including bone pain or fracture, renal failure, susceptibility to infection, anemia, hypercalcemia, and occasionally clotting abnormalities, neurologic symptoms, and manifestations of hyperviscosity. Intracranial lesions of MM commonly involve the cranial vault, the skull base and the orbit [1]. The clivus and petrous regions are far less commonly affected [2]. …
Literature
1.
Cerase A, Tarantino A, Gozzetti A et al (2008) Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology 50(8):665–674CrossRefPubMed
2.
Nofsinger YC, Mirza N, Rowan PT et al (1997) Head and neck manifestations of plasma cell neoplasms. Laryngoscope 107:741–746CrossRefPubMed
3.
Norris CM, Jr., Max L Goodman (1992) Case records of the Massachusetts General Hospital. Weekly clinicopathologic exercises. Case 21—1992. A 65 year old man with a mass that involved the base of the skull. N Eng J med 326:1417–1424CrossRef
4.
Cushing H (1932) Intracranial tumors: notes upon a series of 2000 verified cases with surgical mortality percentages pertain ing to 1932. C.C. Thomas, Baltimore, p 111
5.
6.
Alexander MP, Goodkin DE, Poser CM (1975) Solitary plasmacytoma producing cranial neuropathy. Arch Neurol 32:777–778CrossRefPubMed
7.
Tuncbilek N, Karakas HM, Okten OO, Vural O (2005) MRI in multiple myeloma with orbital and dural invasion. Tumori 91:270–272PubMed
8.
9.
Ustuner Z, Basaran M, Kiris T, Bilgic B, Sencer S, Sakar B, Dizdar Y, Bavbek S, Onat H (2003) Skull base plasmacytoma in a patient with light chain myeloma. Skull Base 13(3):167–171CrossRefPubMedPubMedCentral
10.
Som PM, Brandwein MS (2003) Tumors and tumor-like conditions. In: Som PM, Curtin HD (eds) Head and neck imaging, vol 1, 4th edn. Mosby, St. Louis, pp 261–373
Metadata
Title
Clivus and Dural Involvement in a Case of Multiple Myeloma: A Rare Complication of Multiple Myeloma
Authors
Manish Bhartiya
Aditya Pachisia
Rajan Kapoor
Vasu Vardhan
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0573-7

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue

Correspondence

Lymphocytic Platelet Satellitism

Correspondence

APL-The Age-Old Harlequin: Do We See it All?

Case Report

Treatment of an Elderly Patient with Acute Myeloid Leukemia and Invasive Pulmonary Aspergillosis Infection with Combined Allogeneic Hematopoietic Stem Cells Microtransplantation and Voriconazole

Case Report

Hemophagocytosis by Leukemic Blasts in T Cell Acute Lymphoblastic Leukemia: An Unusual Finding

Case Report

Dysfibrinogenemia with Subgaleal Hematoma: An Unusual Presentation

Correspondence

Cholestasis in a Patient of Multiple Myeloma: A Rare Occurrence of Bortezomib Induced Liver Injury
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits